InsidersTradesSigma
광동제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 광동제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Food & Beverage sector, 광동제약 has recorded 6 insider filings. Market capitalisation: €300bn. The latest transaction was filed on 30 June 2026 (Other). Among the most active insiders: 최성원. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€81,964
3 ops.
Buy Volume
n/a
1 ops.
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,513 of 28,093 companies
51.1
score / 100
Value75
Quality27
FCF yld18%
Earn yld6.8%
EV/EBITDA10.2x
ROE3.3%
Gross mgn18%
Net mgn1.3%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations6 total
6 of 6 declarations
About 광동제약
광동제약 is a South Korean company specializing in the manufacturing of pharmaceutical and health products. It is listed on the XKRX stock exchange.